Loading clinical trials...
Loading clinical trials...
Randomized, Controlled Phase II Clinical Study to Evaluate Superiority of "InbioDerm+C" Autologous Stem Cell-Based Therapy Plus Advanced Healing Compared With Advanced Healing in Diabetic Foot Ulcer Patients
Conditions
Interventions
InbioDerm + C plus advanced healing
Advanced healing
Locations
1
Chile
Centro de Salud Familiar de Villa Alemana
Villa Alemana, Valparaiso, Chile
Start Date
January 2, 2020
Primary Completion Date
May 1, 2022
Completion Date
September 2, 2022
Last Updated
February 10, 2022
NCT07382973
NCT07372404
NCT07330154
NCT07200401
NCT07119983
NCT07261501
Lead Sponsor
Instituto para el Desarrollo Biotecnológico y la Innovación S.A.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions